Home Your basket
• Solitary fibrous tumor of...
   Price 14.00 €
• Viral assumption and inve...
   Price 10.50 €
• Reports to the General As...
   Price 10.50 €
• Massive bone dystrophic l...
   Price 5.50 €
• High click stimulus repet...
   Price 10.50 €
• New indications for heari...
   Price 8.50 €
• Implementation of the Eur...
   Price 10.50 €
• Mucosal melanomas of the ...
   Price 8.50 €
• Tympanoplasty: Experience...
   Price 12.00 €
• Distortion product otoaco...
   Price 10.50 €
• Stingy speakers....
   Price 5.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Tuberculosis of the laryn...
   Price 5.50 €
• Giant metastasis invading...
   Price 5.50 €
• A protocol for the evalua...
   Price 8.50 €
• Complete branchial cleft ...
   Price 5.50 €
• Are we sectioning the coc...
   Price 10.50 €
• Facial paralysis: Functio...
   Price 10.50 €
• Salvage composite resecti...
   Price 10.50 €
• Audit of headache followi...
   Price 5.50 €
• Hearing loss and vestibul...
   Price 10.50 €
• Arachnoid granulations of...
   Price 10.50 €
• Proposition of adaptation...
   Price 10.50 €
• What is the effect of diz...
   Price 10.50 €
• Partial hearing recovery ...
   Price 5.50 €
• Results of alginate and h...
   Price 10.50 €
• Laryngeal cryptococcosis ...
   Price 8.50 €
• Necrotizing external otit...
   Price 10.50 €
• Ectopic thyroid basi-ling...
   Price 10.50 €
• Cottle's technique septop...
   Price 5.50 €
• The application of tusso...
   Price 10.50 €
• A comparative acoustic st...
   Price 5.50 €
• Zenker’s diverticulum in ...
   Price 8.50 €
• Laryngeal neuroendocrin c...
   Price 5.50 €
• Recurrences of pleomorphi...
   Price 10.50 €
• Laryngeal papillomatosis ...
   Price 5.50 €
• Retropharyngeal abscess i...
   Price 10.50 €

Total Order 323.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Download
o Issue N# 1 - 1999 o

CERVICO-FACIAL CARCINOLOGY

Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence ?


Authors : G. Dolivet, P. Colosetti, J. L. Merlin, Cl. Depardieu, M. Lapeyre, E. Wattel, J. Sarini, J. Ton Van, L. Geoffrois, Ph. Lagarde (Vandoeuvre les Nancy)

Ref. : Rev Laryngol Otol Rhinol 1999;120,1:5-12.

Article published in french



Summary : The study of epidemiology and of the carcinogenesis in epidermoid carcinomas of the upper aerodigestive tract shows that their occurrence is not random. Tobacco abuse plays a major role, especially because of benzopyrene, mutagen of the P53 gene, however it is associated with many other potentiating factors : alcohol, metals, hydrocarbures, virus, food, climate, genetic fragility that create genetic lesions at the origin of carcinogenesis. The latter occurs as "field cancerization" with multiple alterations of the mucosa and general attack of the control systems of the differentiation, growth and cell apoptosis which usually protect the cell against the phenomena of carcinogenesis. The P53 protein gene, retinoid receptors as well as the system of detoxifying glutathion S transferase are modified at the very early stage of these diseases, these abnormalities can be logically related to epidemiological data. These date lead us therefore to imagine complementary specific reverting therapies of induced genetic abnormalities, through the reexpression of non mutated gene encoding P53 protein and the use of retinoid. These various modalities are reported hereafter.


|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE